(CRVO) CervoMed - Performance -62.7% in 12m
Compare CRVO with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-77.92%
#132 in Group
Rel. Strength
7.19%
#7407 in Universe
Total Return 12m
-62.70%
#133 in Group
Total Return 5y
-76.68%
#87 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -24.46%
(?) Percentile in Group
12m Total Return: CRVO (-62.7%) vs XBI (-1.8%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-1.68% | 29.3% | 171% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
-0.23% | 21% | 41.1% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-6.62% | 9.44% | 46.9% | 37 | 13.4 | 0.94 | -42.0% | -25.9% |
LONN SW Lonza |
8.56% | 16.2% | 38.7% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
3.94% | 19.8% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-2.63% | -21.7% | 8.36% | 32.4 | 21.5 | 0.27 | 64.4% | 51.8% |
KMDA NASDAQ Kamada |
-2.12% | 27.5% | -10.6% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
14% | -1.49% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
Performance Comparison: CRVO vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CRVO
Total Return (including Dividends) | CRVO | XBI | S&P 500 |
---|---|---|---|
1 Month | -0.98% | 2.28% | -0.87% |
3 Months | 300.88% | -10.48% | -7.58% |
12 Months | -62.70% | -1.83% | 11.88% |
5 Years | -76.68% | -12.72% | 110.33% |
Trend Score (consistency of price movement) | CRVO | XBI | S&P 500 |
1 Month | -42.9% | 56.6% | 23% |
3 Months | 72.3% | -89.3% | -88.5% |
12 Months | -85.1% | -42.4% | 55.1% |
5 Years | -73.7% | -53.6% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #119 | -3.19% | -0.12% |
3 Month | #1 | 348% | 334% |
12 Month | #134 | -62.0% | -66.7% |
5 Years | #87 | -73.3% | -88.9% |
FAQs
Does CRVO CervoMed outperforms the market?
No,
over the last 12 months CRVO made -62.70%, while its related Sector, the SPDR S&P Biotech (XBI) made -1.83%.
Over the last 3 months CRVO made 300.88%, while XBI made -10.48%.
Over the last 3 months CRVO made 300.88%, while XBI made -10.48%.
Performance Comparison CRVO vs Indeces and Sectors
CRVO vs. Indices CRVO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -3.13% | -0.11% | -31.8% | -74.6% |
US NASDAQ 100 | QQQ | -4.16% | -2.38% | -32.2% | -75.4% |
US Dow Jones Industrial 30 | DIA | -2.19% | 2.20% | -31.7% | -71.9% |
German DAX 40 | DAX | -1.90% | -2.30% | -51.3% | -87.4% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.83% | 1.84% | -28.8% | -68.7% |
Hongkong Hang Seng | HSI | -2.14% | -1.04% | -33.7% | -76.6% |
India NIFTY 50 | INDA | -0.29% | -5.04% | -32.1% | -65.8% |
Brasil Bovespa | EWZ | -2.33% | -5.58% | -35.5% | -56.9% |
CRVO vs. Sectors CRVO is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -3.38% | 0.07% | -37.9% | -86.7% |
Consumer Discretionary | XLY | -3.21% | -0.88% | -34.3% | -76.0% |
Consumer Staples | XLP | 0.37% | -1.18% | -37.1% | -73.9% |
Energy | XLE | 1.35% | 12.9% | -26.0% | -51.6% |
Financial | XLF | -1.74% | 1.13% | -39.4% | -85.4% |
Health Care | XLV | -3.05% | 2.81% | -30.1% | -64.4% |
Industrial | XLI | -3.55% | -1.09% | -32.5% | -72.3% |
Materials | XLB | -2.52% | 1.45% | -24.4% | -59.2% |
Real Estate | XLRE | -1.61% | 0.33% | -30.9% | -80.8% |
Technology | XLK | -5.58% | -2.67% | -28.4% | -70.4% |
Utilities | XLU | -0.29% | -1.04% | -33.9% | -84.5% |
Aerospace & Defense | XAR | -4.08% | -7.37% | -45.3% | -89.3% |
Biotech | XBI | -4.43% | -3.26% | -19.1% | -60.9% |
Homebuilder | XHB | -2.44% | 1.29% | -17.0% | -55.7% |
Retail | XRT | -1.56% | -0.42% | -26.2% | -60.0% |